University of Maryland, Baltimore: Diabetes Mellitus, Type 2 trials

The registry lists 10 Diabetes Mellitus, Type 2 studies with University of Maryland, Baltimore as lead sponsor. 1 are open to participants now and 4 have results posted.

Early Phase 1 3Phase 1 3Phase 2 1Phase 4 1No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Pharmacogenetics of Response to GLP1R AgonistsRecruitingNCT05071898Phase 1
• Pharmacogenomics of GLP1 Receptor AgonistsTerminatedNCT05762744Phase 1Results posted
• Pharmacogenomics of ThiazolidinedionesCompletedNCT01135394Not applicableResults posted
• Examining Genetic Influence on Response to Beta-Blocker Medications in People With Type 2 DiabetesTerminatedNCT00925119Phase 4Results posted
• Metabolic Causes of Thrombosis in Type 2 Diabetes - Question 4CompletedNCT00574340Early Phase 1Results posted
• The Effect of Donepezil on Glycemic Control in Type II DiabeticsTerminatedNCT04507438Phase 2
• Genetics of Response to CanagliflozinActive, not recruitingNCT02891954Phase 1
• GLP-1 and HypoglycemiaActive, not recruitingNCT01858896Early Phase 1
• Metabolic Causes of Thrombosis in Type 2 Diabetes MellitusCompletedNCT00829699Early Phase 1
• Effects of Pramlintide on Endogenous Production of Very-low-density-lipoprotein (VLDL)-Triglyceride and Glucose in the Post Prandial State in T2DMWithdrawnNCT00732147Not applicable